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Receptors for the tachykinin family of peptides were investigated in 
human and rat skin areas using quantitative receptor autoradio-
graphy and emulsion autoradiography with 125I-Bolton-Hunter sub-
stance P (125I-BH-substance P), a non-selective radioligand, and 125I-
Bolton-Hunter eledoisin (125I-BH-eledoisin), a selective radioligand for 
the tachykinin NK-2 receptor. There were no differences between 
localization of specific 125I-BH-substance P and 125I-BH-eledoisin bind-
ing sites in human and rat skin. The highest densities of the binding 
sites were in the dermal papillae of the human finger pad skin and the 
rat paw pad skin. In cold-ligand saturation experiments done in the 
presence of increasing concentrations of unlabeled substance P, 125I-
BH-substance P binding to the rat and human dermal papillae was 
single and of a high affinity. 125I-BH-eledoisin bound to the dermal 
papillae with a much lower affinity than 125I-BH-substance P did. The 
rank order of potency of unlabeled tachykinin peptides to displace 125I-
BH-substance P binding to the dermal papillae of the human finger 
pad skin and rat paw pad skin was substance P > eledoisin > 
neurokinin A >> neurokinin B. Thus, the methods we used revealed 
that the tachykinin NK-1 receptor is predominantly present in the 
skin dermal papilla.
Introduction 
Primary sensory neurons with substance P, a member of 
the tachykinin family of peptides, originating from the 
dorsal root ganglia are widely distributed in skin." Skin 
organelles, such as sweat glands, hair follicles, and Meis-
ner's corpuscles are richly innervated by substance P-
containing neurons. 2,3,4) In addition to the organelles, skin 
blood vessels are possible target sites of the neurons, as 
evidence has revealed the pathophysiological significance 
of substance P in cutaneous inflammatory responses in-
cluding vasodilation and plasma protein extravasation.5.6.'' 
 Immunohistochemical studies have led to identification 
of free nerve endings of substance P neurons within dermal 
papilla,' 8' a finding which supports the role of substance P 
in pain transmission, as mediated by nociceptor in skin."') 
 The mammalian tachykinin family of peptides," 12) sub-
stance P, neurokinin A, neurokinin B, neuropeptide K and 
neuropeptide y, which have an amino acid sequence, -Phe-
X-Gly-Leu-Met at the C terminus in common, exert physi-
ological functions, by interacting with at least three sub-
types of receptors, the NK-1, the NK-2 and the NK-3
receptors. l3, 14, 15) In contrast to morphological and functional 
findings, far less is known of properties of tachykinin 
receptors in areas of the skin. Using the quantitative recep-
tor autoradiographic method with two radioligands, 125I-
Bolton-Hunter substance P (125I-BH-substance P), a radio-
ligand for the tachykinin receptors,"' and 125I-Bolton-Hunter 
eledoisin (125I-BH-eledoisin), a radioligand for the NK-2 
receptor,") we investigated tachykinin receptors in rat and 
human skin.
Materials and Methods 
Materials 
'25I-BH-substance P and 125I-BH-eledoisin were purchased 
from the New England Nuclear, U.S.A., and peptides and 
drugs used were from the Peninsula lab., U.S.A., the Sigma 
Chemical Co., U.S.A., and the Peptide Institute, Japan. 
 Male Wistar rats weighting 250g to 300g were given 
standards chow (F-2, Funabashi Farm Co., Japan) and 
water ad libitum and were housed at 24°C, with lights on 
from 07:00 hr to 19:00 hr at the laboratory Animal Center 
for the Biomedical Research, Nagasaki University School 
of Medicine, Japan. The rats were decapitated between 
10:00 hr and 12:00 hr, and skins from the dorsum, abdo-
men and paw pad were immediately removed. Human 
dorsal and pad skins of a finger and toe were obtained from 
7-, 12- and 18-month-old boys and girls with polydactylia. 
Human scalp skins were surgically dissected from three 
patients undergoing treatment for alopecia. Rat and human 
skins were immersed at -30°C, and stored at -80°C. Frozen 
sections, 16-,um-thick, were cut on a cryostat at -16°C, 
thaw-mounted on gelatin-coated glass slides and stored 
overnight under vaccum at 4°C. 
Quantitative Receptor Autoradiography 
Related tissue sections were labeled in vitro with 125I-
BH-substance P (specific activity, -81.4 TBq/mmol) or 125I-
BH-eledoisin (specific activity, -81.4 TBq/mmol) in 2.0 ml 
of incubation box, under the conditions described."' After 
preincubation in the incubation buffer at room temperature
(23°C) for 15min, related tissue sections were incubated 
with the radioligands at 23V for 90 min in 50 mM Tris-
HC1 buffer (pH 7.4) containing 0.2 mg/ml bovine serum 
albumin, 40 1tg/ml bacitracin, 4 ,ug/ml leupeptin, 50 ,ug/ml 
chymostatin, and 5 mM MnC 12. Non-specific binding was 
determined in adjacent sections, incubated with the same 
amounts of the radioligands in the presence of 1.0 ,u M 
unlabeled substance P, eledoisin, neurokinin A or neu-
rokinin B. To characterize the binding sites, we incubated 
consecutive, related sections with a fixed amount of the 
radioligands in the absence or presence of increasing con-
centrations of unlabeled peptides, ranging from 1.0 pM to 
10 1tM. After incubation, the slides were washed four 
times (30 sec each) at 4 °C in 50 mM Tris-HC 1 buffer (pH 
7.4) and rinsed quickly in ice-cold distilled water. Sections 
were dried under a stream of cold air and exposed to 3H-
Ultrofilm (LKB, U. S. A.) with calibrated 1251-standards ([125 
I] micro-scale, Amersham). The films were developed at 4 
°C for 7 min
, using a D19 developer (Eastman Kodak, 
U.S.A.). The optical densities, measured by computerized 
microdensitometry (UHG-101, Unique Medical Co., Ja-
pan), were related to the concentration of radioactivity, as 
based on a comparison with standard curves generated 
processing sets of standards with each autoradiogram. "' 
Emulsion autoradiography 
To observe cellular localization of 1251-BH-substance P and 
125I-BH-eledoisin binding sites, we performed emulsion 
autoradiography.'a' After exposure to 3H-Ultrofilm, related 
tissue sections were washed three times (15 sec each) in 
cold (4°C) distilled water. Sections were defatted in xylene 
and alcohol rinses, and then dipped into Kodak NTB-3 
nuclear emulsion (Eastman Kodak, U.S.A.). Coated slides 
were stored in dark at 49C for 5 days in the case of "'I-
13H-substance P binding and for 10 days for 12SI-
BH-eledoisin binding. After these exposure, the slides were 
developed at 169C for 5 min, using a D19 developer and 
counterstained with eosin, and coverslips were added. 
Data analysis 
The data obtained by quantitative receptor autoradiographic 
studies were analyzed using the LIGAND computer pro-
gram.","' Results were expressed as means ± S.E.M. 
Differences in the data were assessed by one-way analysis 
of variance (ANOVA) using the F test.
Results 
Localization of '251-BH-substance P and `251-BH-eledoisin 
binding sites in human and rat skin 
Fig. 1 shows receptor autoradiographic localization of "'I-
BH-substance P binding sites in the finger pad skin ob-
tained from a thumb excised from a 12-month-old boy with 
polydactylia (A), and from a rat paw pad skin (B). High 
densities of "'I-BH-substance P binding sites were present 
in the dermal papilla and sweat gland. 125I-BH-eledoisin 
also richly labeled the dermal papilla and sweat gland. 
There were no differences between the receptor autoradio-
graphic localization of "'I-BH-substance P and '2SI-
BH-eledoisin binding sites in human and rat skin. Non-
specific binding sites were detected in adjacent sections 
when the incubations were carried out in the presence of 
1.0 1tM unlabeled substance P and eledoisin, respectively 
(Figs. 1 and 2 #2 panel). 
  Light microscopic examination of emulsion autoradio-
graphy revealed '25I-BH-substance P binding in the dermal 
papilla of the human finger pan skin to be over the vascular 
endothelial cells (arrow A in Fig. 3) and areas devoid of 
vascular components (arrow B). We compared binding 
sites of 1251-BH-substance P with those of '251-BH-eledoisin. 
As shown in Fig. 4, cellular localization of 1251-BH-
eledoisin binding sites was comparable to that of "'I-BH-
substance P.
Fig. 1. Typical receptor autoradiograms of 125I-Bolton-Hunter 
substance P (12'I-BH-substance P) binding sites in the finger pad 
skin obtained from a thumb excised from a 12-month-old boy 
with polydactylia (A), and from a rat paw pad skin (B). Consec-
utive, 16-gm-thick tissue sections were incubated with 100 pM 
125I-BH-substance P, without (total binding, 2) or with 1.0 ,u M 
unlabeled substance P (non-specific binding, 3). Dried sections 
were exposed to 3H-Hyperfilm for 4 days. Adjacent sections were 
stained with hematoxylin-eosin to observe the anatomy (1). DP, 
dermal papilla; SG, sweat gland. Bar = 1.0 mm.
Fig. 2. Typical receptor autoradiograms of 125I-Bolton-Hunter 
eledoisin (125I-BH-eledoisin) binding sites in the finger pad skin 
obtained from a rat paw pad skin (A) and from a thumb excised 
from a 7-month-old with polydactylia (B). Cosecutive, 16-,um-
thick tissue sections were incubated with 350 pM 125I-
BH-eledoisin, without (total binding, 2) or with 10 , t M unlabeled 
eledoisin (non-specific binding, 3). Dried sections were exposed 
to 'H-Ultrofilm for 10 days. Adjacent sections were stained with 
hematoxylin-eosin to observe the anatomy (1). DP, dermal papil-
la; SG, sweat gland. Bar = 1.0 mm
Fig. 4. An emulsion autoradiogram of 125I-Bolton-Hunter eledoi-
sin (1211-BH-eledoisin) binding to dermal papilla of the finger pad 
skin obtained from a thumb excised from a 7-month-old boy with 
polydactylia (upper panel). Dots indicated by arrows A and B 
represent "'I-BH-eledoisin binding to the capillary endothelium 
and areas which lack vascular components, respectively. A dark-
field photomicrograph of the autoradiogram are shown in the 
lower panel of the figure. DP, dermal papilla; E, epidermis. Bar = 
40,um.
Fig. 3. An emulsion autoradiogram of 125I-Bolton-Hunter sub-
stance P (125I-BH-substance P) binding to dermal papilla of the 
finger pad skin obtained from a thumb excised from a 12-month-
old boy with polydactylia. Dots indicated by arrows A and B 
represent 125I-BH-substance P binding to the capillary endothelium 
and areas which lack vascular components, respectively. N, 
nucleus of capillary endothelial cells; DP, dermal papilla; E, 
epidermis. Bar = 40 ,um.
Concentrations of specific 1251-BH-substance P and 1251-
BH-eledoisin binding sites in human and rat skin 
Apparent specific "'I-131-1-substance P and "'I-BH-eledoisin 
binding concentrations in human and rat skin were calcu-
lated by subtracting non-specific binding concentrations 
obtained at incubation with 100 pM of the radioligands in 
the presence of 1.0 ,u M unlabeled substance P or 10 u M 
eledoisin from total binding concentrations (Table 1). 
Among the human skin tissues examined, the highest "'I-
131-1-substance P and 1251-BH-eledoisin binding densities 
were noted in the dermal papilla of the finger pad skin. In 
case of rat skin, the paw pad skin had the highest densities 
of both radioligands in the dermal papilla and the sweat 
gland. Therefore, we focused the following binding experi-
ments on the dermal papillae of the rat paw pad skin and
Table 1. Quantitative determination of 125I-Bolton-Hunter substance P ('25I-BH-SP) and 125I-Bolton-Hunter eledoisin ('25I-BH-EL) binding 
sites in human and rat skin. Sections were incubated with 100 pM of the radiolabeled ligands. Optical densites were converted into 
fmo/mg. Non-specific binding was subtracted from all readings, individually. Results are means ± S.E.M. of findings in 3-6 human and 
rat skin samples.
                                       Dermal papilla Sweat gland 
                                         '211-BH-SP 125I-BH-EL '2'I-BH-SP '211-BH-EL 
   Human 
     Scalp skin (3) 1.39 ± 0.43 0.40 ± 0.16 (0.08 ± 0.45*) (0.09 ± 0.05*) 
     Finger dorsal skin (6) 2.52 ± 0.52 0.28 ± 0.09 2.08 ± 0.31 0.26 ± 0.11 
     Finger pad skin (6) 2.76 ± 0.14 0.54 ± 0.15 2.41 ± 0.32 0.28 ± 0.08 
     Toe tip skin (6) 2.33 ± 0.62 0.36 ± 0.11 1.63 ± 0.70 0.21 ± 0.10 
   Rat 
     Back skin (6) 1.04 ± 0.24 0.13 ±0.06 0.47 ± 0.45 0.05 ± 0.02 
     Abdominal skin (6) 0.58 ± 0.13 0.07 ± 0.03 0.30 ± 0.18 0.02 ± 0.01 
     Paw pad skin (6) 2.10+-0.34 0.36 ± 0.09 2.04 ± 0.61 0.23 ± 0.15 
*Data on binding sites in the hair follicle.
the human finger pad skin. 
Characteristics of '25I-BH-substance P and '25I-BH-eledoi-
sin binding to dermal papillae of rat paw pad and human 
finger pad skin 
Specific '25I-BH-substance P and '25I-BH-eledoisin binding 
characteristics in the dermal papillae of the rat paw pad 
skin and the human finger pad skin were examined in a 
cold-ligand saturation study, in the presence of fixed 
amounts of the radioligands, 85 pM or 94 pM 125I-BH-
substance P, and 350 pM pM 125I-BH-eledoisin, respec-
tively, and increasing concentrations of unlabeled sub-
stance P or eledoisin, ranging from 10 pM to 10 uM. "'I-
BH-substance P binding to the dermal papillae of the rat 
paw pad skin and the human finger pad skin was displaced 
by unlabled substance P, with a high affinity (Fig. 5, inset). 
The program LIGAND fitted the data to a one-site model 
significantly better than it did to a two-site model, as 
evidenced by the straight line of the Scatchard plot (Fig. 5). 
  "'I-BH-substance P thus presumably bound to a single 
population of sites in the dermal papillae of the rat paw pad 
skin and the human finger pad skin, with a dissociation 
constant (Kd) of 297 pM and 744 pM, respectively. 
  125I-BH-eledoisin binding to the dermal papillae of the 
rat paw pad skin and the human finger pad skin was also 
saturable and single (Fig. 6 and Fig. 7). However, in 
contrast to "'I-BH-substance P binding, the affinites of 125I-
Fig. 5. A typical cold-ligand saturation experiment of specific 125I-
Bolton-Hunter substnace p (125I-BH- substance P) binding to the 
dermal papillae of the finger pad skin obtained from a thumb 
excised from a 12-month-old boy with polydactylia (0) (94 pM) 
and the rat paw pad skin (• ) (85 pM). Scatchard plots were 
obtained by displacing the binding of 125I-BH-substance P by 
unlabeled substance P (inset in the figure), analyzed using the 
computer program LIGAND.
Fig. 6. A typical cold-ligand saturation specific experiment of 125I-
Bolton-Hunter eledoisin (125I-BH-eledoisin) binding to the dermal 
papilla of the finger pad skin obtained from a thumb excised from 
a 7-month-old boy with polydactylia (350 pM). A Scatchard plot 
was obtained by displacing the binding of 125I-BH-eledoisin by 
unlabeled eledoisin (inset in the figure), analyzed using the com-
puter program LIGAND.
Fig. 7. A typical cold-ligand saturation experiment of specific 125 
I-Bolton-Hunter eledoisin (125I-BH-eledoisin) binding to the der-
mal papilla of the rat paw pad skin (radioligand concentration, 350 
pM). A Scatchard plot was obtained by dipsplacing the binding of '251-BH-eledoisin by unlabeled eledoisin (inset in the figure), 
analyzed using the computer program LIGAND. The binding 
characteristics, dissociation constant (Kd) and maximum binding 
capacity (B-) were calculated to be 16.5 nM and 9.2 fmo/mg.
BH-eledoisin binding calculated were much lower. Further-
more, the radioligand for the tachykinin NK-2 receptor 
bound to the dermal papilla of the rat paw pad skin with a 
higher affinity than it did to the human finger pad skin. The 
binding parameters, Kd and maximum binding capacity 
(B,,,ax) of specific 125I-BH-substance P and 125I-BH-eledoisin 
binding to the dermal papillae of the rat paw pad skin and 
the human finger pad skin are listed in Table 2.
Fig. 8. Typical displacement curves of specific 125I-Bolton-Hunter 
substance P (125I-BH-substance P) to the dermal papilla of the rat 
paw pad skin (right side in the figure; radioligand concentration 
94 pM) and the finger pad skin from a thumb excised from a 
12-month-old boy with polydactylia (left side in the figure; radio-
ligand concentration, 94 pM) by unlabeled substance P (40), 
eledoisin (0), neurokinin A (A&) and neurokinin B (A).
Table 3. Affinities (IC50, nM) of related tachykinins for specific 125 
I-Bolton-Hunter sudstance P (125I-BH-sudstance P) binding to 
dermal papillae of rat paw pad skin and human finger pad skin. 
IC50 is concentration of peptide displacing 50% of specifically 
bound '25I-BH-substance P. Results are means ± S.E.M. of 3 
determinations.
  Peptide Rat Human 
substance P 0.99 ± 0.56 0.72 ± 0.33 
eledoisin 9.32 ± 2.56 9.88 ± 5.43 
neurokinin A 92.7 ± 15.3 960 ± 249 
neurokinin B 730 ± 195 x 10 > 104
Table 2. Binding parameters, dissociation constant (K,) and 
maximum binding capacity (B„,) of specific 125I-BH-substance P 
and 1251-BH-eledoisin binding to dermal papillae of rat paw pad 
skin and human finger pad skin. Results are means ± S.E.M. of 
findings in 3 human and 6 rat skin.
                '251-BH-substance P 125I-BH-eledoisin 
               Rat Human Rat Human 
Kd (nM) 0.30 ± 10 0.74 ± 0.70 13.3 ± 4.3' 224 ± 160` 
B,,, (fmol/mg) 11.3±3.5 8.2±2.0 7.5±2.6b 225±1234 
P < 0.01 (a < c, b < d).
 We then compared the potencies of the tachykinin family 
of peptides, substance P, eledoisin, neurokinin A and 
neurokinin B, at displacing '25I-BH-substance P binding to 
the dermal papillae of the rat paw pad skin and the human 
finger pad skin (Fig. 8 and Table 3). 125I-BH-substance P 
binding was potently inhibited by substance P. The potency 
of eledoisin for displacing binding was lower than that of 
substance P. Neurokinin B was the weakest inhibitor, 
however, interestingly, the peptide with a high affinity for 
the NK-3 receptors displaced '25I-BH-substance P binding
to the rat dermal papilla more potently (Fig. 8 right side 
panel) than to the human dermal papilla (left side panel). 
Also, we noted the less potency of neurokinin A, a tachy-
kinin for the NK-2 receptor, at displacing 125I-BH-substance 
P binding to the human dermal papilla, as compared with 
that in the case of binding to the rat dermal papilla. Thus, 
the rank order potency to displace 125I-BH-substance P 
binding to the rat and human dermal papillae was substance 
P > eledoisin > neurokinin A > neurokinin B, and sub-
stance P >> eledoisin >> neurokinin A >>> neurokinin B, 
respectively.
Discussion 
The mammalian tachykinin family of peptides, substance P, 
neurokinin A, neurokinin B, neuropeptide K and neuro-
peptide y, participate in physiological functions as neuro 
transmitters in the central and peripheral nervous sys-
tem,"', 21) and chemical mediators related to inflammatory
responses. 22) These peptides increase cytosolic free Ca 2+ 
concentration in target cells, presumably by interacting 
with at least three types of specific receptors, functionally 
linked to the activation of phospholipase C and to the 
mobilization of intracellular Ca2+,23.1, classified recently as 
three subtypes"-","); the NK-1 receptor, preferentially 
recognized by substance P with a much higher affinity than 
neurokinin A and neurokinin B, the NK-2 receptor, which 
is mainly activated by neuropeptide y and is bound by 
eledoisin with a high affinity, and the third type of the 
NK-3 receptor. 
 These receptors have been extensively studied in the 
central nervous system and the gastrointestinal tract sys-
tem. 15. 2S,26,27,28) However, there is little information on the 
receptor, as related to skin, although it has been established 
that sensory nerves are involved in cutaneous inflammatory 
responses including vasodilation and plasma protein extra-
vasation.5.6' We found specific 125I-BH-substance P and 125I-
BH-eledoisin binding sites to be discretely localized in rat 
and human skin areas correspondingly anatomically to the 
dermal papilla. As presented, 125I-BH-substance P specif-
ically bound to the dermal papilla with a Kd value in a 
subnanomolar range, and the Kd of the binding sites for 
125I-BH-eledoisin , a radioligand for the NK-2 receptor,"' 
was calculated to have a supernanomolar value. Our emul-
sion autoradiography revealed that there were no differ-
ences in cellular localization of 125I-BH-substance P and 
1251-BH-eledoisin binding sites . Taken together with the 
observation that neurokinin A, an endogenous ligand for 
the tachykinin NK-2 receptor,") and neurokinin B, a selec-
tive ligand for. the NK-3 receptor,") were weak displacers 
for 125I-BH-substance P binding, it may be true that specific 
1211-13H-substance P binding sites present in the dermal 
papilla is characteristically the NK-1 receptor. 
  We also noted the difference between the affinity of 
neurokinin B at displacing 125I-BH-substance P binding to 
the rat and human dermal papillae. This may be evidence 
suggesting the existence of a further heterogeneity of the 
NK-1 receptor. Moreover, 125I-BH-eledoisin bound to the 
rat dermal papilla with a much higher affinity than it did to 
the human dermal papilla. The possibility of the existence 
of a tiny amount of the NK-2 receptor in the rat dermal 
papilla is not ruled out. Neurokinin A-containing sensory 
neurons coexisting with substance P-containing neurons 
are present in the rat skin .3) 
  Density and localization of the tachykinin NK-1 receptor 
correspond to the distribution of substance P-containing 
neurons in the skin dermal papilla .1,21,3') This differed from 
evidence on the receptor-transmitter mismatch in the sub-
stance P system in the central nervous system.31' 
  Of particular interest was the present observation that the 
highest density of the tachykinin receptor was in the dermal 
papilla, since the area contains substantial numbers of 
substance P-containing free nerve endings."') The free 
nerve endings are thought to be a nociceptor exerting pain
transmission. 9.32' Taking note of the present observation that 
the tachykinin receptors are in an area of the dermal papilla 
which lacks the vascular component such as the capillary 
endothelium, the possibility that the tachykinin receptors 
are located on presynaptic sites of the free nerve endings 
would have to be considered. Furthermore, the number of 
the receptor in the dermal papilla was the highest in the 
finger pad skin, an area most richly innervated by primary 
sensory neurons, as compared with abdominal, dorsal, and 
scalp skin.") Therefore, sudstance P released from free 
nerve endings may relate to pain transmission, by inter-
acting with the tachykinin NK-1 receptor. 
  Substance P released by antidromic stimulation to axon 
collaterals of the primary sensory neurons seems to act on 
the capillary epithelium, and results in an increase in 
plasma extravasation.32, 33' If such is indeed the case, then 
this would explain mechanisms related to neurogenic in-
flammation. There is the view that substance P participates 
in this phenomenon by stimulating receptors present in 
mast cells to release histamine.') Our evidence for the 
existence of the tachykinin NK-1 receptor over the capil-
lary epithelium indicates that substance P may be involved 
in neurogenic inflammation. 
  In summary, we have obtained evidence to support the 
idea that tachykinin functions within the skin dermal papil-
la as a neurotransmitter and/or neuromodulator. Although 
the NK-1 receptor seems to be predominant, the existence 
of the other subtype of the tachykinin receptors cannot be 
excluded. The precise heterogeneity of the receptors can be 
elucidated by in situ hybridization technique with the re-
spective receptor gene probe.
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